SC
EDIT icon

Saturna Capital’s Editas Medicine EDIT Stock Holding History

Saturna Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,625
Closed -$441K – 175
2021
Q4 		$441K Buy
16,625
+125
+0.8% +$4.3K 0.01% 135
2021
Q3 		$678K Hold
16,500
– – 0.01% 115
2021
Q2 		$935K Buy
16,500
+5,750
+53% +$212K 0.02% 110
2021
Q1 		$452K Buy
10,750
+650
+6% +$37K 0.01% 131
2020
Q4 		$708K Sell
10,100
-100
-1% -$4.11K 0.02% 116
2020
Q3 		$286K Hold
10,200
– – 0.01% 147
2020
Q2 		$302K Buy
10,200
+100
+1% +$2.61K 0.01% 145
2020
Q1 		$200K Buy
10,100
+3,200
+46% +$80.7K 0.01% 165
2019
Q4 		$204K Buy
+6,900
New +$172K 0.01% 185

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Saturna Capital's EDIT Position: Q1 2022 in Review

Saturna Capital sold out of Editas Medicine (EDIT) in Q1 2022, closing a stake of 16,625 shares — an estimated $441K sold.

Saturna Capital first reported a position in EDIT in Q4 2019 and held it in 9 quarters. The position peaked at $935K in Q2 2021. 256 funds tracked by Wall St. Rank hold EDIT as of Q1 2022.

  • Saturna Capital reported no remaining Editas Medicine position as of Q1 2022 after selling out during the quarter.
  • Saturna Capital sold 16,625 Editas Medicine shares in Q1 2022, an estimated $441K.
  • Saturna Capital first reported a position in Editas Medicine in Q4 2019 and held it in 9 quarters.
  • Saturna Capital's Editas Medicine position peaked at $935K in Q2 2021.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2022.

Based on Saturna Capital's 13F filing for Q1 2022, filed 10 May 2022.